Broncus 

$0.080000
0
+$0.00+0% Tuesday 20:00

統計

當日最高
0.08
當日最低
0.08
52週高點
0.08
52週低點
0.08
成交量
10,000
平均成交量
0
市值
40.05M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

27Aug預期
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.02
0.31
0.65
0.98
預期EPS
不適用
實際EPS
-0.02

財務

-10,272.99%利潤率
未盈利
2020
2021
2022
2023
2024
2025
174,000營收
-17.88M淨利

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Broncus Holding Corporation is a medical technology enterprise dedicated to advancing interventional pulmonology through the development of specialized products. Its operational reach extends across key markets including Mainland China, the European Union, the United States, and other international regions. The company's product portfolio is broadly categorized into navigation and treatment solutions. Navigation offerings include: LungPoint Virtual Bronchoscopic Navigation: A sophisticated, computer-assisted software system that utilizes imaging for virtual bronchoscopic guidance. LungPoint Plus: This system provides real-time navigational assistance within the airways, crucial for lung biopsies and various other pulmonological procedures. LungPro: A virtual bronchoscopic navigation tool that facilitates three-dimensional, real-time guided transbronchial needle aspiration and features proprietary parenchymal navigation capabilities. Its comprehensive suite of treatment products comprises: InterVapor: A targeted bronchoscopic thermal vapor ablation method designed to treat diseased, hyper-inflated lung segments. RF Generator + RF Ablation Catheter: A radiofrequency ablation system specifically engineered for use with a disposable lung radiofrequency ablation catheter, targeting lung cancer. H-Marker: A specialized marker for pulmonary surgical applications. Furthermore, Broncus provides essential procedural accessories and tools such as: BioStarNeedle: A single-use, ultrasound-guided aspiration needle for efficiently collecting tissue samples. FleXNeedle: A versatile biopsy needle adaptable for multiple purposes. Archimedes Sheath: A sterile, single-use flexible tube that establishes a working channel during bronchoscopic interventions. Archimedes Dilation Balloon: A sterile, single-use flexible tube equipped with a balloon at its tip, inserted via a bronchoscope or sheath to dilate targeted lung tissue within the bronchial tree. Steerable Sheath: Featuring a steerable adjustment handle and a working channel for enhanced maneuverability. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.
Show more...
執行長
Hong Xu
員工
191
國家
開曼群島
ISIN
KYG1609T1022

上市

0 Comments

分享你的想法

FAQ

Broncus 今天的股價是多少?
BRNHF 目前價格為 $0.08 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Broncus 股價表現。
Broncus 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,Broncus 的股票以代號 BRNHF 進行交易。
Broncus 的股價在上漲嗎?
BRNHF 股票較上週上漲 +0%,本月上漲 +0%,過去一年 Broncus 上漲 +0%。
Broncus 的市值是多少?
今天 Broncus 的市值為 40.05M
Broncus 下一次財報日期是什麼時候?
Broncus 將於 March 31, 2027 公布下一次財報。
Broncus 上一季度的財報如何?
BRNHF 上一季度的財報為每股 -0.02 USD,預估為 不適用 USD,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 USD。
Broncus 去年的營收是多少?
Broncus 去年的營收為 174,000USD。
Broncus 去年的淨利是多少?
BRNHF 去年的淨收益為 -17.88MUSD。
Broncus 有多少名員工?
截至 September 04, 2026,公司共有 191 名員工。
Broncus 位於哪個產業?
Broncus從事於Health & Wellness產業。
Broncus 何時完成拆股?
Broncus 最近沒有進行任何拆股。
Broncus 的總部在哪裡?
Broncus 的總部位於 開曼群島 的 Hangzhou。